Physician profile
Brandon Armstrong Kiel
NPI 1841731007
$9,880.59
in general payments reported to CMS, 2019-2025
8 companies · $8,337 in 2025
The $8,337 reported for 2025 was more than what 95% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.53 · 2020: $14.38 · 2021: $127 · 2022: $292 · 2024: $1,094 · 2025: $8,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,250 · Travel and Lodging: $2,400 · Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,250.00 |
| Travel and Lodging | $2,399.80 |
| Food and Beverage | $780.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,299.90 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,093.82 | 2024 | Ribfix Blu Advantage, Advantagerib |
| Atricure, INC. | $157.69 | 2022 | |
| Integra Lifesciences Corporation | $134.74 | 2022 | |
| Medtronic, INC. | $126.57 | 2021 | |
| Ethicon US, LLC | $36.96 | 2025 | Megadyne |
| Pacira Pharmaceuticals Incorporated | $16.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Kiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.